BridgeMD
New treatment option for Radiculopathy
Official title Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy
ClinicalTrials.gov ID: NCT05952167
What this study is testing
- What it's testing
- Cervical radiculopathy is a common disease related to compression of the nerve roots of the spine (prevalence: 3.5/1000). Dysfunction and pain are the main repercussions and can lead to time off work and high costs in terms of treatment.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18
- Neck Disability Index ≥ 15/50
- Presence of at least three of the four signs clinically validating the presence of cervical radiculopathy (Wainner et al. 2003)
- a) upper limb nerve tension test A (ULNT1a): positive,
- b) amplitude of cervical rotation on the side concerned: \< 60°,
You likely can't join if
- Patients with vertebral artery pathology at the time of inclusion
- Patients with myelopathy, cervical cancer, cervical fracture, cervical dislocation, cervical spondylolisthesis, spinal infection, symptomatic...
- Patient participating in another clinical research protocol with an impact on the objectives of the research.
- Patient who is pregnant, breastfeeding or able to procreate without effective contraception\ .
- Patient under guardianship, curatorship or deprived of liberty
- Patient under activated future protection mandate
See the full eligibility criteria
- Patient over 18
- Neck Disability Index ≥ 15/50
- Presence of at least three of the four signs clinically validating the presence of cervical radiculopathy (Wainner et al. 2003)
- a) upper limb nerve tension test A (ULNT1a): positive,
- b) amplitude of cervical rotation on the side concerned: \< 60°,
- c) positive cervical distraction test: relief
- d) positive Spurling test: reproduction of symptoms.
- Cervical radiculopathy diagnosed 3 to 24 months previously
- Absence of cervical traction in the 5 years prior to inclusion
- MRI or CT scan performed prior to hospitalisation in relation to current pathology
- Patient able to understand the protocol and having given oral informed consent to take part in the research.
- Patient affiliated to the social security system or entitled beneficiary.
- Patients with vertebral artery pathology at the time of inclusion
- Patients with myelopathy, cervical cancer, cervical fracture, cervical dislocation, cervical spondylolisthesis, spinal infection, symptomatic cervical pain without radiculopathy and/or cervical surgery in the 2 years...
- Patient participating in another clinical research protocol with an impact on the objectives of the research.
- Patient who is pregnant, breastfeeding or able to procreate without effective contraception\ .
- Patient under guardianship, curatorship or deprived of liberty
- Patient under activated future protection mandate
- Patient under family habilitation
- Patient under court protection.
The study team makes the final eligibility decision.
Where it's taking place
- La Roche-sur-Yon, France
- La Rochelle, France
- Le Puy-en-Velay, France
- Limoges, France
- Nantes, France
- Paris, France
- Reims, France
- Rouen, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include La Roche-sur-Yon, France; La Rochelle, France; Le Puy-en-Velay, France; Limoges, France; Nantes, France; Paris, France and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.